Insulet Income from Continuous Operations 2010-2024 | PODD
Insulet annual/quarterly income from continuous operations history and growth rate from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- Insulet income from continuous operations for the quarter ending December 31, 2024 was $0.101B, a 2.52% decline year-over-year.
- Insulet income from continuous operations for the twelve months ending December 31, 2024 was $0.418B, a 102.76% increase year-over-year.
- Insulet annual income from continuous operations for 2024 was $0.418B, a 102.76% increase from 2023.
- Insulet annual income from continuous operations for 2023 was $0.206B, a 4384.78% increase from 2022.
- Insulet annual income from continuous operations for 2022 was $0.005B, a 72.62% decline from 2021.
| Insulet Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $418 |
| 2023 | $206 |
| 2022 | $5 |
| 2021 | $17 |
| 2020 | $7 |
| 2019 | $12 |
| 2018 | $3 |
| 2017 | $-27 |
| 2016 | $-27 |
| 2015 | $-62 |
| 2014 | $-48 |
| 2013 | $-45 |
| 2012 | $-52 |
| 2011 | $-46 |
| 2010 | $-61 |
| 2009 | $-72 |
| Insulet Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-12-31 | $101 |
| 2024-09-30 | $78 |
| 2024-06-30 | $189 |
| 2024-03-31 | $52 |
| 2023-12-31 | $103 |
| 2023-09-30 | $52 |
| 2023-06-30 | $27 |
| 2023-03-31 | $24 |
| 2022-12-31 | $17 |
| 2022-09-30 | $-5 |
| 2022-06-30 | $-35 |
| 2022-03-31 | $28 |
| 2021-12-31 | $29 |
| 2021-09-30 | $13 |
| 2021-06-30 | $-25 |
| 2021-03-31 | |
| 2020-12-31 | $-17 |
| 2020-09-30 | $12 |
| 2020-06-30 | $14 |
| 2020-03-31 | $-2 |
| 2019-12-31 | $5 |
| 2019-09-30 | $1 |
| 2019-06-30 | $1 |
| 2019-03-31 | $4 |
| 2018-12-31 | $10 |
| 2018-09-30 | $2 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-7 |
| 2017-12-31 | $-7 |
| 2017-09-30 | $-2 |
| 2017-06-30 | $-8 |
| 2017-03-31 | $-10 |
| 2016-12-31 | $-9 |
| 2016-09-30 | $-3 |
| 2016-06-30 | $-4 |
| 2016-03-31 | $-11 |
| 2015-12-31 | $-16 |
| 2015-09-30 | $-18 |
| 2015-06-30 | $-17 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-11 |
| 2014-06-30 | $-29 |
| 2014-03-31 | $-6 |
| 2013-12-31 | $-3 |
| 2013-09-30 | $-21 |
| 2013-06-30 | $-11 |
| 2013-03-31 | $-11 |
| 2012-12-31 | $-10 |
| 2012-09-30 | $-12 |
| 2012-06-30 | $-14 |
| 2012-03-31 | $-15 |
| 2011-12-31 | $-14 |
| 2011-09-30 | $-14 |
| 2011-06-30 | $-8 |
| 2011-03-31 | $-10 |
| 2010-12-31 | $-21 |
| 2010-09-30 | $-12 |
| 2010-06-30 | $-14 |
| 2010-03-31 | $-14 |
| 2009-12-31 | $-16 |
| 2009-09-30 | $-17 |
| 2009-06-30 | $-20 |
| 2009-03-31 | $-20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.442B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.058B | 28.41 |
| Boston Scientific (BSX) | United States | $149.209B | 40.19 |
| Stryker (SYK) | United States | $142.084B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $131.854B | 0.00 |
| Medtronic (MDT) | Ireland | $115.249B | 16.83 |
| Haleon (HLN) | United Kingdom | $46.488B | 26.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $44.527B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.909B | 17.98 |
| Agilent Technologies (A) | United States | $33.351B | 22.03 |
| ResMed (RMD) | United States | $32.876B | 25.32 |
| Terumo (TRUMY) | Japan | $27.805B | 39.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.874B | 17.05 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.530B | 14.15 |
| Baxter (BAX) | United States | $17.557B | 12.63 |
| Sunny Optical Technology (SNPTF) | China | $12.864B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
| Demant (WILYY) | Denmark | $8.048B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.822B | 23.62 |
| Lantheus Holdings (LNTH) | United States | $6.684B | 16.43 |
| Prestige Consumer Healthcare (PBH) | United States | $4.259B | 20.32 |
| Perrigo (PRGO) | Ireland | $3.826B | 10.95 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.405B | 29.11 |
| Haemonetics (HAE) | United States | $3.193B | 15.02 |
| Envista Holdings (NVST) | United States | $2.972B | 23.64 |
| QuidelOrtho (QDEL) | United States | $2.359B | 19.76 |
| GN Store Nord (GNNDY) | Denmark | $2.336B | 15.74 |
| LeMaitre Vascular (LMAT) | United States | $1.893B | 43.25 |
| Neogen (NEOG) | United States | $1.881B | 21.67 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.462B | 14.08 |
| Kestra Medical Technologies (KMTS) | $1.234B | 0.00 | |
| InMode (INMD) | Israel | $1.234B | 10.31 |
| Green Thumb Industries (GTBIF) | United States | $1.233B | 19.37 |
| BioLife Solutions (BLFS) | United States | $1.073B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.865B | 13.27 |
| Evolus (EOLS) | United States | $0.765B | 0.00 |
| Owens & Minor (OMI) | United States | $0.698B | 5.94 |
| CeriBell (CBLL) | United States | $0.689B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.601B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.562B | 0.00 |
| Valneva SE (VALN) | France | $0.545B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.478B | 20.71 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.436B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.433B | 0.00 |
| SNDL (SNDL) | Canada | $0.371B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| ZimVie (ZIMV) | United States | $0.301B | 18.00 |
| Viemed Healthcare (VMD) | United States | $0.288B | 26.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Quanterix (QTRX) | United States | $0.252B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 43.90 |
| Verano Holdings (VRNOF) | United States | $0.233B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 14.19 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Brainsway (BWAY) | Israel | $0.178B | 55.71 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| High Tide (HITI) | Canada | $0.153B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.144B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.140B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.116B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.112B | 13.99 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 12.18 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 24.44 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| Exagen (XGN) | United States | $0.064B | 0.00 |
| InterCure (INCR) | Israel | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 12.66 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.50 |
| Safety Shot (SHOT) | United States | $0.027B | 0.00 |
| INLIF (INLF) | $0.021B | 0.00 | |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |